Cargando…

A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers

BACKGROUND: The genetic variation underlying atorvastatin (ATV) pharmacokinetics was evaluated in a Mexican population. Aims of this study were: 1) to reveal the frequency of 87 polymorphisms in 36 genes related to drug metabolism in healthy Mexican volunteers, 2) to evaluate the impact of these pol...

Descripción completa

Detalles Bibliográficos
Autores principales:	León-Cachón, Rafael B. R., Ascacio-Martínez, Jorge A., Gamino-Peña, María E., Cerda-Flores, Ricardo M., Meester, Irene, Gallardo-Blanco, Hugo L., Gómez-Silva, Magdalena, Piñeyro-Garza, Everardo, Barrera-Saldaña, Hugo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746878/ https://www.ncbi.nlm.nih.gov/pubmed/26857559 http://dx.doi.org/10.1186/s12885-016-2062-2

Ejemplares similares

Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial
por: Gómez-Silva, Magdalena, et al.
Publicado: (2019)

The atorvastatin metabolic phenotype shift is influenced by interaction of drug-transporter polymorphisms in Mexican population: results of a randomized trial
por: León-Cachón, Rafael B. R., et al.
Publicado: (2020)

DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics
por: Turic, Darko, et al.
Publicado: (2010)

Expanding the Spectrum of Dopa-Responsive Dystonia (DRD) and Proposal for New Definition: DRD, DRD-plus, and DRD Look-alike
por: Lee, Woong-Woo, et al.
Publicado: (2018)

Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis
por: Miuli, Andrea, et al.
Publicado: (2020)

Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity
por: Loganayagam, A, et al.
Publicado: (2013)

A novel method to detect the Mexican founder mutation BRCA1 ex9-12del associated with breast and ovarian cancer using quantitative polymerase chain reaction and TaqMan(®) probes
por: Martínez-Treviño, Denisse Aideé, et al.
Publicado: (2018)

Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World
por: Fernández-Garza, Luis E., et al.
Publicado: (2023)

The Modification of Offspring Stress-Related Behavior and the Expression of Drd1, Drd2, and Nr3c1 by a Western-Pattern Diet in Mus Musculus
por: Clauss, Nikki, et al.
Publicado: (2022)

Association Between DRD2 and DRD4 Polymorphisms and Eating Disorders in an Italian Population
por: Ceccarini, Maria Rachele, et al.
Publicado: (2022)

Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains
por: Mill, Jonathan, et al.
Publicado: (2005)

Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum
por: Oude Ophuis, Ralph J. A., et al.
Publicado: (2014)

Unravelling the interaction between the DRD2 and DRD4 genes, personality traits and concussion risk
por: Abrahams, Shameemah, et al.
Publicado: (2019)

Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow
por: Niu, Hongmei, et al.
Publicado: (2018)

The 1316T>C missenses mutation in MTHFR contributes to MTHFR deficiency by targeting MTHFR to proteasome degradation
por: Liu, Xi, et al.
Publicado: (2020)

No association of DRD2, DRD3, and tyrosine hydroxylase gene polymorphisms with personality traits in the Japanese population
por: Hibino, Hiroyuki, et al.
Publicado: (2006)

Prevalence of polymorphisms in the ANKK1, DRD2, DRD3 genes and metabolic syndrome in refractory schizophrenia
por: Pinto, Jeizziani Aparecida Ferreira, et al.
Publicado: (2018)

Información genética : estructura, función y manipulación
por: Barrera Saldaña, Hugo A.

Comparison of the Impact of Pharmacogenetic Variability on the PK of Slow Release and Immediate Release Tacrolimus Formulations
por: van Gelder, Teun, et al.
Publicado: (2020)

Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?
por: Jelovac, Marina, et al.
Publicado: (2023)

DRD2 and DRD4 genes related to cognitive deficits in HIV-infected adults who abuse alcohol
por: Villalba, Karina, et al.
Publicado: (2015)

Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders
por: del Casale, Antonio, et al.
Publicado: (2022)

DRD1 and DRD4 are differentially expressed in breast tumors and breast cancer stem cells: pharmacological implications
por: Rosas-Cruz, Arely, et al.
Publicado: (2022)

Personalized Medicine in Ovarian Cancer: A Perspective From Mexico
por: Fernandez-Garza, Luis E., et al.
Publicado: (2021)

A gene × gene interaction between DRD2 and DRD4 is associated with conduct disorder and antisocial behavior in males
por: Beaver, Kevin M, et al.
Publicado: (2007)

DRD4, DRD2, DAT1, and ANKK1 Genes Polymorphisms in Patients with Dual Diagnosis of Polysubstance Addictions
por: Masiak, Jolanta, et al.
Publicado: (2020)

The Role of DRD1 and DRD2 Receptors for Response Selection Under Varying Complexity Levels: Implications for Metacontrol Processes
por: Zink, Nicolas, et al.
Publicado: (2019)

Genetic Polymorphisms on OPRM1, DRD2, DRD4, and COMT in Young Adults: Lack of Association With Alcohol Consumption
por: Chung, Patrick, et al.
Publicado: (2020)

Pharmacogenetics of OATP Transporters Reveals That SLCO1B1 c.388A>G Variant Is Determinant of Increased Atorvastatin Response
por: Rodrigues, Alice C., et al.
Publicado: (2011)

ApoB gene polymorphism (rs676210) and its pharmacogenetics impact on atorvastatin response among Iraqi population with coronary artery disease
por: Abdulfattah, Shaimaa Y., et al.
Publicado: (2021)

The Tumor Necrosis Factor α (-308 A/G) Polymorphism Is Associated with Cystic Fibrosis in Mexican Patients
por: Sanchez-Dominguez, Celia N., et al.
Publicado: (2014)

The Association of DRD2 with Insight Problem Solving
por: Zhang, Shun, et al.
Publicado: (2016)

Association study between COMT, DRD2, and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophrenia
por: Escamilla, Raul, et al.
Publicado: (2018)

Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia
por: Taheri, Narges, et al.
Publicado: (2023)

Gene Polymorphisms and Pharmacogenetics in Rheumatoid Arthritis
por: Rego-Pérez, Ignacio, et al.
Publicado: (2008)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of Mycobacterium tuberculosis
por: Martínez-González, María Alejandrina, et al.
Publicado: (2021)

Dopamine Genes (DRD2/ANKK1-TaqA1 and DRD4-7R) and Executive Function: Their Interaction with Obesity
por: Ariza, Mar, et al.
Publicado: (2012)

Parental smoke exposure and the development of nicotine craving in adolescent novice smokers: the roles of DRD2, DRD4, and OPRM1 genotypes
por: Kleinjan, Marloes, et al.
Publicado: (2015)

DRD2, DRD3, and HTR2A Single-Nucleotide Polymorphisms Involvement in High Treatment Resistance to Atypical Antipsychotic Drugs
por: Del Casale, Antonio, et al.
Publicado: (2023)

Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review)
por: Rodríguez-Rodríguez, Diana Raquel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o6o2qi9amra6omau0u1m9sfjiq